Lugen Zuo

3PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 04, 2021
Epac-2 ameliorates spontaneous colitis in Il-10-/- mice by protecting the intestinal barrier and suppressing NF-κB/MAPK signalling.

Xue Song, Hexin Wen, Lugen Zuo

|Jun 19, 2019
Spontaneous colitis in IL-10-deficient mice was ameliorated via inhibiting glutaminase1.

Jing Li, Lugen Zuo, Yun Tian

Pageof 1